Helicobacter pylori binds to CD74 on gastric epithelial cells and stimulates interleukin-8 production

被引:53
作者
Beswick, EJ
Bland, DA
Suarez, G
Barrera, CA
Fan, XJ
Reyes, VE
机构
[1] Univ Texas, Med Branch, Dept Pediat, Galveston, TX 77555 USA
[2] Univ Texas, Med Branch, Dept Pathol, Galveston, TX 77555 USA
[3] Univ Texas, Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA
关键词
D O I
10.1128/IAI.73.5.2736-2743.2005
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The pathogenesis associated with Helicobacter pylori infection requires consistent contact with the gastric epithelium. Although several cell surface receptors have been suggested to play a role in adhesion, the bacterium-host interactions that elicit host responses are not well defined. This study investigated the interaction of H. pylori with the class II major histocompatibility complex (MHC)-associated invariant chain (Ii; CD74), which was found to be highly expressed by gastric epithelial cells. Bacterial binding was increased when CD74 surface expression was increased by gamma interferon (IFN-gamma treatment or by fibroblast cells transfected with CD74, while binding was decreased by CD74 blocking antibodies, enzyme cleavage of CD74, and CD74-coated bacteria. H. pylori was also shown to bind directly to affinity-purified CD74 in the absence of class II MHC. Cross-linking of CD74 and the engagement of CD74 were verified to stimulate IL-8 production by unrelated cell lines expressing CD74 in the absence of class II MHC. Increased CD74 expression by cells increased IL-8 production in response to H. pylori, and agents that block CD74 decreased these responses. The binding of H. pylori to CD74 presents a novel insight into an initial interaction of H. pylori with the gastric epithelium that leads to upregulation of inflammatory responses.
引用
收藏
页码:2736 / 2743
页数:8
相关论文
共 44 条
  • [1] Lymphocytes in the human gastric mucosa during Helicobacter pylori have a T helper cell 1 phenotype
    Bamford, KB
    Fan, XJ
    Crowe, SE
    Leary, JF
    Gourley, WK
    Luthra, GK
    Brooks, EG
    Graham, DY
    Reyes, VE
    Ernst, PB
    [J]. GASTROENTEROLOGY, 1998, 114 (03) : 482 - 492
  • [2] Differential glycosylation of MHC class II molecules on gastric epithelial cells: Implications in local immune responses
    Barrera, C
    Espejo, R
    Reyes, VE
    [J]. HUMAN IMMUNOLOGY, 2002, 63 (05) : 384 - 393
  • [3] The role of the invariant chain in mucosal immunity
    Barrera, CA
    Almanza, RJ
    Ogra, PL
    Reyes, VE
    [J]. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1998, 117 (02) : 85 - 93
  • [4] Stimulation of IL-8 production in human gastric epithelial cells by Helicobacter pylori, IL-1 beta and TNF-alpha requires tyrosine kinase activity, but not protein kinase C
    Beales, ILP
    Calam, J
    [J]. CYTOKINE, 1997, 9 (07) : 514 - 520
  • [5] Role of NF-κB and AP-1 on Helicobater pylori-induced IL-8 expression in AGS cells
    Chu, SH
    Kim, H
    Seo, JY
    Lim, JW
    Mukaida, N
    Kim, KH
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2003, 48 (02) : 257 - 265
  • [6] Coccoid and spiral Helicobacter pylori differ in their abilities to adhere to gastric epithelial cells and induce interleukin-8 secretion
    Cole, SP
    Cirillo, D
    Kagnoff, MF
    Guiney, DG
    Eckmann, L
    [J]. INFECTION AND IMMUNITY, 1997, 65 (02) : 843 - 846
  • [7] CRABTREE JE, 1994, EUR J GASTROEN HEPAT, V6, pS33
  • [8] Helicobacter pylori induces apoptosis in human epithelial gastric cells by stress activated protein kinase pathway
    Domek, MJ
    Netzer, P
    Prins, B
    Nguyen, T
    Liang, D
    Wyle, FA
    Warner, A
    [J]. HELICOBACTER, 2001, 6 (02) : 110 - 115
  • [9] Helicobacter pylori
    Dunn, BE
    Cohen, H
    Blaser, MJ
    [J]. CLINICAL MICROBIOLOGY REVIEWS, 1997, 10 (04) : 720 - +
  • [10] THE INVARIANT CHAIN IS REQUIRED FOR INTRACELLULAR-TRANSPORT AND FUNCTION OF MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II MOLECULES
    ELLIOTT, EA
    DRAKE, JR
    AMIGORENA, S
    ELSEMORE, J
    WEBSTER, P
    MELLMAN, I
    FLAVELL, RA
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (02) : 681 - 694